MX2015003665A - Microcapsulas biodegradables que contienen material de relleno. - Google Patents

Microcapsulas biodegradables que contienen material de relleno.

Info

Publication number
MX2015003665A
MX2015003665A MX2015003665A MX2015003665A MX2015003665A MX 2015003665 A MX2015003665 A MX 2015003665A MX 2015003665 A MX2015003665 A MX 2015003665A MX 2015003665 A MX2015003665 A MX 2015003665A MX 2015003665 A MX2015003665 A MX 2015003665A
Authority
MX
Mexico
Prior art keywords
filling material
microcapsules containing
biodegradable
containing filling
biodegradable microcapsules
Prior art date
Application number
MX2015003665A
Other languages
English (en)
Spanish (es)
Inventor
Kinam Park
Christopher A Rhodes
Original Assignee
Akina Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akina Inc filed Critical Akina Inc
Publication of MX2015003665A publication Critical patent/MX2015003665A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Dermatology (AREA)
MX2015003665A 2012-09-20 2013-09-20 Microcapsulas biodegradables que contienen material de relleno. MX2015003665A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261703723P 2012-09-20 2012-09-20
PCT/US2013/060922 WO2014047439A1 (en) 2012-09-20 2013-09-20 Biodegradable microcapsules containing filling material

Publications (1)

Publication Number Publication Date
MX2015003665A true MX2015003665A (es) 2016-03-08

Family

ID=50341971

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015003665A MX2015003665A (es) 2012-09-20 2013-09-20 Microcapsulas biodegradables que contienen material de relleno.
MX2019002575A MX2019002575A (es) 2012-09-20 2015-03-20 Microcapsulas biodegradables que contienen material de relleno.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2019002575A MX2019002575A (es) 2012-09-20 2015-03-20 Microcapsulas biodegradables que contienen material de relleno.

Country Status (9)

Country Link
US (3) US20150265541A1 (https=)
EP (1) EP2897593A4 (https=)
JP (2) JP2015532928A (https=)
KR (1) KR20150090038A (https=)
AU (3) AU2013317899A1 (https=)
BR (1) BR112015006087A2 (https=)
HK (1) HK1214127A1 (https=)
MX (2) MX2015003665A (https=)
WO (1) WO2014047439A1 (https=)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2538929A4 (en) 2010-02-25 2014-07-09 Univ Johns Hopkins DELAYED RELEASE OF THERAPIES IN A PART OF THE EYE
US10307372B2 (en) 2010-09-10 2019-06-04 The Johns Hopkins University Rapid diffusion of large polymeric nanoparticles in the mammalian brain
WO2012109363A2 (en) 2011-02-08 2012-08-16 The Johns Hopkins University Mucus penetrating gene carriers
CA2863632C (en) 2012-01-19 2017-07-11 The Johns Hopkins University Nanoparticle formulations with enhanced mucosal penetration
US8962577B2 (en) 2012-03-16 2015-02-24 The Johns Hopkins University Controlled release formulations for the delivery of HIF-1 inhibitors
JP6138904B2 (ja) 2012-03-16 2017-05-31 ザ・ジョンズ・ホプキンス・ユニバーシティー 活性剤の送達のための非線状マルチブロックコポリマー薬物コンジュゲート
KR102310775B1 (ko) 2012-05-03 2021-10-07 칼라 파마슈티컬스, 인크. 개선된 점막 수송을 나타내는 제약 나노입자
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
AU2013256064B2 (en) 2012-05-03 2018-01-04 Alcon Inc. Pharmaceutical nanoparticles showing improved mucosal transport
AU2013256008B2 (en) 2012-05-04 2016-02-25 The Johns Hopkins University Lipid-based drug carriers for rapid penetration through mucus linings
WO2014124006A1 (en) 2013-02-05 2014-08-14 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
WO2015127368A1 (en) 2014-02-23 2015-08-27 The Johns Hopkins University Hypotonic microbicidal formulations and methods of use
CN107635545A (zh) 2015-01-27 2018-01-26 约翰霍普金斯大学 用于增强粘膜表面处活性剂的输送的低渗水凝胶制剂
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
US20170273911A1 (en) * 2016-03-23 2017-09-28 Boston Scientific Scimed Inc. Injectable microspheres
CN109790143A (zh) 2016-05-10 2019-05-21 C4医药公司 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
CN109641874A (zh) 2016-05-10 2019-04-16 C4医药公司 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
EP3454862B1 (en) 2016-05-10 2024-09-11 C4 Therapeutics, Inc. Spirocyclic degronimers for target protein degradation
EP4491236A3 (en) 2016-05-10 2025-04-02 C4 Therapeutics, Inc. Heterocyclic degronimers for target protein degradation
RU2018145364A (ru) 2016-06-27 2020-07-28 Ачиллион Фармасьютикалс, Инк. Хиназолиновые и индольные соединения для лечения медицинских нарушений
EP3858835A1 (en) 2016-07-01 2021-08-04 G1 Therapeutics, Inc. Pyrimidine-based antiproliferative agents
CN109862945B (zh) * 2016-10-28 2022-03-08 联合利华知识产权控股有限公司 包含颗粒的个人护理组合物
BR112019008463B1 (pt) 2016-10-28 2022-06-07 Unilever Ip Holdings B.V. Composição para a higiene pessoal
CN110603252A (zh) 2017-03-01 2019-12-20 艾其林医药公司 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物
EP4717317A2 (en) 2017-06-20 2026-04-01 C4 Therapeutics, Inc. N/o-linked degrons and degronimers for protein degradation
JP2021519337A (ja) 2018-03-26 2021-08-10 シー４ セラピューティクス， インコーポレイテッド Ｉｋａｒｏｓの分解のためのセレブロン結合剤
WO2020041301A1 (en) 2018-08-20 2020-02-27 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
WO2020051532A2 (en) 2018-09-06 2020-03-12 Achillion Pharmaceuticals, Inc. Macrocyclic compounds for the treatment of medical disorders
EP3866773B1 (en) 2018-10-16 2024-08-28 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
WO2020149684A2 (ko) * 2019-01-18 2020-07-23 주식회사 대하맨텍 인체에 자극이 없어 안전하고 생분해가 가능한 캡슐 및 그의 제조방법
KR102272566B1 (ko) * 2019-01-18 2021-07-05 주식회사 대하맨텍 인체에 자극이 없어 안전하고 생분해가 가능한 캡슐 및 그의 제조방법
FR3091878B1 (fr) 2019-01-22 2023-06-16 Calyxia Compositions de produits d’entretien avec des propriétés olfactives améliorées
FR3091877B1 (fr) 2019-01-22 2023-06-16 Calyxia Compositions de detergence avec des propriétés olfactives améliorées
US12496279B2 (en) 2019-04-11 2025-12-16 The Johns Hopkins University Nanoparticles for drug delivery to brain
CN120172958A (zh) 2019-04-12 2025-06-20 C4医药公司 Ikaros和aiolos的三环降解物
WO2021168320A1 (en) 2020-02-20 2021-08-26 Achillion Pharmaceuticals, Inc. Heteroaryl compounds for treatment of complement factor d mediated disorders
AU2021231898A1 (en) 2020-03-05 2022-10-27 C4 Therapeutics, Inc. Compounds for targeted degradation of BRD9
ES3048084T3 (en) 2020-05-19 2025-12-09 Pharmacosmos Holding As Cyclin-dependent kinase inhibiting compounds for the treatment of medical disorders
WO2022066774A1 (en) 2020-09-23 2022-03-31 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement mediated disorders
WO2024184188A1 (en) * 2023-03-03 2024-09-12 Danmarks Tekniske Universitet A method for preparing microparticles for drug delivery

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001388A (en) * 1973-06-14 1977-01-04 Alza Corporation Ophthalmological bioerodible drug dispensing formulation
US4865846A (en) * 1988-06-03 1989-09-12 Kaufman Herbert E Drug delivery system
AU2001298061A1 (en) * 2000-12-13 2003-07-09 Purdue Research Foundation Microencapsulation of drugs by solvent exchange
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
BRPI0516308A2 (pt) * 2004-10-04 2010-06-15 Qlt Usa Inc composição fluida, métodos de tratamento de uma doença ou disfunção, métodos de liberação local ou sistêmica de um agente biológico, implantes, método de formação de um implante, kit de agente biológico e usos de uma composição fluida
JP4856881B2 (ja) * 2005-02-01 2012-01-18 川澄化学工業株式会社 薬剤徐放システム
KR20080059175A (ko) * 2005-09-07 2008-06-26 사우스웨스트 리서치 인스티튜트 방출속도가 향상된 생분해성 미립자 약제학적 제제
JP5201763B2 (ja) * 2007-02-28 2013-06-05 昇一 城武 異なる平均粒径サイズの粒子からなる混合微粒子カプセルの製造方法
US8071119B2 (en) * 2007-05-14 2011-12-06 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
CA2700356C (en) * 2007-09-27 2013-07-09 Akina, Inc. Sol-gel phase-reversible hydrogel templates and uses thereof
US20130316010A1 (en) * 2010-10-18 2013-11-28 Case Western Reserve University Polymeric microparticles

Also Published As

Publication number Publication date
MX2019002575A (es) 2019-10-30
US20200390715A1 (en) 2020-12-17
KR20150090038A (ko) 2015-08-05
AU2013317899A1 (en) 2015-05-07
JP2015532928A (ja) 2015-11-16
HK1214127A1 (zh) 2016-10-07
AU2020202735A1 (en) 2020-05-14
WO2014047439A1 (en) 2014-03-27
EP2897593A1 (en) 2015-07-29
BR112015006087A2 (pt) 2017-07-04
US20150265541A1 (en) 2015-09-24
AU2018204552A1 (en) 2018-07-12
EP2897593A4 (en) 2016-04-06
JP2019014729A (ja) 2019-01-31
US20180185296A1 (en) 2018-07-05
AU2013317899A8 (en) 2015-05-28

Similar Documents

Publication Publication Date Title
MX2019002575A (es) Microcapsulas biodegradables que contienen material de relleno.
ZA201506934B (en) Aerosol comprising distributing agent and a medicament source
IL234815A0 (en) Heat-manufactured unbreakable pharmaceutical dosage form containing zinc
IL237101B (en) A secondary part, a system that includes a dental implant and the secondary part, and a package that includes the system
PL2895279T3 (pl) Dezynfekcja, sterylizacja i pakowanie produktów gotowych do spożycia
SG11201501793SA (en) Water-absorbent resin, water-absorbent material, and water-absorent article
AU346743S (en) Cap for a container
ZA201500252B (en) Portion capsule having an identification on the inner periphery thereof
AU201714610S (en) Fragrance Capsule
IL237068A (en) 1,3-dioxanomorphides and 1,3-dioxanocodides
EP3068442A4 (en) Bionanofluid for use as a contrast, imaging, disinfecting and/or therapeutic agent
IL240592B (en) A medical device for the treatment of aneurysm, which includes an antithrombotic agent
SI2739615T1 (sl) Fenil-3-aza-biciklo(3.1.0)heks-3-il-metanoni in njihova uporaba kot zdravilo
GB201307917D0 (en) Vaporisable material plug and capsule
PH12015500384A1 (en) Polyolefin composition
AU344931S (en) Package
EP2851059A4 (en) DEVICE FOR FILLING A MEDICAL AGENT
EP2905319A4 (en) TREATMENT AGENT AND COSMETIC MATERIAL CONTAINING A COMODIFIED ORGANOPOLYSILOXANE
GB201407760D0 (en) Vaporisable material and capsule
BR112014029212A2 (pt) composição de agente de clarificação. composição de resina e artigo moldado
HUE042638T2 (hu) Egy szilárd nanorészecskébõl és legalább egy antigénbõl álló gyógyszerészeti összetétel intracelluláris kórokozó elleni kezelésre
EP2940146A4 (en) HIGH-FUNCTIONAL IMPLANT MATERIAL
IL238788A0 (en) sema5b peptides and components containing them
IL240192A (en) Medication for the prevention or treatment of constipation
EP3008992A4 (en) PACKAGING FOR ANIMAL EXCREMENT PROCESSING MATERIAL AND CONTAINER FOR ANIMAL EXCREMENT PROCESSING MATERIAL